Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
88.63
+0.88 (1.00%)
At close: Nov 20, 2024, 4:00 PM
88.40
-0.23 (-0.26%)
Pre-market: Nov 21, 2024, 5:09 AM EST
Gilead Sciences Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Gilead Sciences stock have an average target of 93.91, with a low estimate of 69 and a high estimate of 125. The average target predicts an increase of 5.96% from the current stock price of 88.63.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for GILD stock from 24 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 2 | 2 | 3 |
| Buy | 2 | 3 | 3 | 4 | 8 | 9 |
| Hold | 11 | 11 | 11 | 11 | 10 | 12 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 17 | 17 | 17 | 20 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Maintains $81 → $84 | Hold | Maintains | $81 → $84 | -5.22% | Nov 18, 2024 |
| Wolfe Research | Wolfe Research | Buy Initiates $110 | Buy | Initiates | $110 | +24.11% | Nov 15, 2024 |
| Citigroup | Citigroup | Strong Buy Initiates $125 | Strong Buy | Initiates | $125 | +41.04% | Nov 14, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 8, 2024 |
| Truist Securities | Truist Securities | Hold Maintains $83 → $97 | Hold | Maintains | $83 → $97 | +9.44% | Nov 8, 2024 |
Financial Forecast
Revenue This Year
28.66B
from 27.12B
Increased by 5.71%
Revenue Next Year
28.77B
from 28.66B
Increased by 0.37%
EPS This Year
4.30
from 4.50
Decreased by -4.52%
EPS Next Year
7.54
from 4.30
Increased by 75.50%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 30.1B | 30.8B | 32.2B | ||
| Avg | 28.7B | 28.8B | 29.7B | ||
| Low | 26.7B | 26.5B | 27.4B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.0% | 7.4% | 11.8% | ||
| Avg | 5.7% | 0.4% | 3.3% | ||
| Low | -1.4% | -7.5% | -4.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 4.94 | 8.74 | 9.14 | ||
| Avg | 4.30 | 7.54 | 7.96 | ||
| Low | 3.50 | 6.25 | 6.39 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.7% | 103.3% | 21.1% | ||
| Avg | -4.5% | 75.5% | 5.6% | ||
| Low | -22.3% | 45.5% | -15.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.